...
首页> 外文期刊>Pharmacoepidemiology and drug safety >Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011.
【24h】

Safe lists for medications in pregnancy: inadequate evidence base and inconsistent guidance from Web-based information, 2011.

机译:怀孕用药的安全清单:证据不足,网上信息指南不一致,2011年。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Medication use during pregnancy is common and increasing. Women are also increasingly getting healthcare information from sources other than their physicians.This report summarizes an environmental scan that identified 25 active Internet sites that list medications reported to be safe for use in pregnancy and highlights the inadequate evidence base and inconsistent guidance provided by these sites.These lists included 245 different products, of which 103 unique components had been previously evaluated in terms of fetal risk by the Teratogen Information System (TERIS), a resource that assesses risk of birth defects after exposure under usual conditions by consensus of clinical teratology experts. For 43 (42%) of the 103 components that were listed as 'safe' on one or more of the Internet sites surveyed, the TERIS experts were unable to determine the fetal risk based on published scientific literature. For 40 (93%) of these 43, either no data were available to assess human fetal risk or the available data were limited.Women who see a medication on one of these 'safe' lists would be led to believe that there is no increased risk of birth defects resulting from exposure. Thus, women are being reassured that fetal exposure to these medications is safe even though a sufficient evidence base to determine the relative safety or risk does not exist. Copyright ? 2013 John Wiley & Sons, Ltd.
机译:怀孕期间使用药物很普遍,而且还在增加。妇女也越来越多地从医生以外的其他来源获得医疗保健信息。该报告总结了一次环境扫描,发现了25个活跃的互联网站点,列出了据报道可安全用于妊娠的药物,并着重指出了这些站点提供的证据不足和指导不一致这些清单包括245种不同产品,其中30种独特成分先前已通过Teratogen信息系统(TERIS)在胎儿风险方面进行了评估,该资源通过临床畸形学专家的共识评估了在通常情况下暴露后的出生缺陷风险。 。在被调查的一个或多个互联网站点上被列为“安全”的103个组件中,有43个(42%)的TERIS专家无法根据已发表的科学文献来确定胎儿的风险。在这43名中的40名(93%)中,要么没有可用的数据来评估人类胎儿的风险,要么可用的数据有限。在这些“安全”清单之一上看到药物的妇女将被认为没有增加的数据。暴露导致出生缺陷的风险。因此,即使没有足够的证据来确定相对安全性或风险,也可以使妇女放心,胎儿接触这些药物是安全的。版权? 2013 John Wiley&Sons,Ltd.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号